Statement Of Cash Flows [Abstract]

BioArctic - Filing #688739

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-01-01	As at 2020-01-01
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)	—	17 442 SEK	—	139 723 SEK	—	—
Adjustments to reconcile profit (loss) [abstract]
Adjustments for decrease (increase) in other operating receivables	—	2 414 SEK	—	5 122 SEK	—	—
Adjustments for increase (decrease) in other operating payables	—	27 328 SEK	—	62,000 SEK	—	—
Other adjustments for non-cash items	—	41 234 SEK	—	5 230 SEK	—	—
Cash flows from (used in) operations	—	31 638 SEK	—	140 457 SEK	—	—
Interest paid, classified as operating activities	—	751,000 SEK	—	984,000 SEK	—	—
Interest received, classified as operating activities	—	2 535 SEK	—	388,000 SEK	—	—
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities	—	12 746 SEK	—	4 386 SEK	—	—
Other inflows (outflows) of cash, classified as investing activities	—	18,000 SEK	—	27,000 SEK	—	—
Cash flows from (used in) investing activities	—	12 763 SEK	—	4 412 SEK	—	—
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities	—	8 793 SEK	—	7 389 SEK	—	—
Dividends paid, classified as financing activities	—	5 985 SEK	—	- SEK	—	—
Cash flows from (used in) financing activities	—	2 808 SEK	—	7 389 SEK	—	—
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	—	47 209 SEK	—	152 257 SEK	—	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	—	4 190 SEK	—	723,000 SEK	—	—
Cash and cash equivalents	805 386 SEK	—	848 405 SEK	—	848 405 SEK	999 940 SEK